Brief: AB Science Announces Launch Of A Capital Increase
21/04/2023 21:29
April 21 (Reuters) - Ab Science Sa ABS.PA :
* ANNOUNCES THE IMPLEMENTATION OF A NEW STRATEGY AND THE
LAUNCH OF
A CAPITAL INCREASE
* CAPITAL INCREASE THROUGH ISSUANCE OF NEW ORDINARY SHARES
VIA
PRIVATE PLACEMENT FOR MAXIMUM AMOUNT OF ABOUT 15.0 MILLION
EUROS
* CAPITAL INCREASE WOULD ENTAIL AN ISSUANCE OF 2,608,695
SHARES
WITH ATTACHED WARRANTS
Source text for Eikon: ID:nGNE2357sn
Further company coverage: ABS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041